1. Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes

   • Victor M. Lu
   • Krishnan Ravindran
   • Michael J. Link

   Topic Review 28 June 2019 Pages: 239 - 248

   

2. Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?

   • Charissa A. C. Jessurun
   • Alexander F. C. Hulsbergen
   • Marike L. D. Broekman

   Topic Review Open access 25 July 2019 Pages: 249 - 264

3. Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme

   • P. A. Chen
   • G. Shrivastava
   • Christopher Power

   Laboratory Investigation 06 July 2019 Pages: 265 - 273

   

4. Comparison of ABC/2 estimation and a volumetric computerized method for measurement of meningiomas using magnetic resonance imaging

   • Charles F. Opalak
   • Matthew Parry
   • William C. Broaddus

   Clinical Study 10 August 2019 Pages: 275 - 282

   

5. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping

   • Tejpal Gupta
   • Madan Maitre
   • Aliasgar Moiyadi

   Clinical Study 24 June 2019 Pages: 283 - 291

   

6. MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma

   • Yi Chai
   • Caixia Wang
   • Yuqi Zhang

   Clinical Study 24 June 2019 Pages: 293 - 301

   

7. Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)

   • John D. Hainsworth
   • Kevin P. Becker
   • Kent Shih

   Clinical Study 07 August 2019 Pages: 303 - 311

   

8. Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery

   • Philip C. De Witt Hamer
   • Vincent K. Y. Ho
   • on behalf of the Quality Registry Neuro Surgery glioblastoma working group from the Dutch Society of Neurosurgery

   Clinical Study Open access 24 June 2019 Pages: 313 - 323

   

9. Single-fraction stereotactic radiosurgery for spindle cell oncocytoma: preliminary experience and systematic review of the literature

   • Soliman Oushy
   • Christopher S. Graffeo
   • Bruce E. Pollock

   Clinical Study 28 June 2019 Pages: 325 - 332

   

10. Analysis of patterns of failure and appraisal of postoperative radiation field for grade II–III meningioma

    • Jason Joon Bock Lee
    • Jeongshim Lee
    • Chang-Ok Suh

    Clinical Study 05 July 2019 Pages: 333 - 341

    

11. Fractionated stereotactic radiotherapy for local control of resected brain metastases

    • Jeffrey I. Traylor
    • Ahmed Habib
    • Ganesh Rao

    Clinical Study 16 July 2019 Pages: 343 - 350

    

12. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer

    • Chengcheng Gui
    • Namrata Chintalapati
    • Kristin Janson Redmond

    Clinical Study 13 July 2019 Pages: 351 - 358

    

13. Phase II study of Dovitinib in recurrent glioblastoma

    • Mayur Sharma
    • Cathy Schilero
    • Manmeet S. Ahluwalia

    Clinical Study 11 July 2019 Pages: 359 - 368

    

14. Treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center

    • Ryan N. Nachwalter
    • Robert J. Rothrock
    • Daniel S. Higginson

    Clinical Study 23 July 2019 Pages: 369 - 376

    

15. Multidimensional assessment of fatigue in patients with brain metastases before and after Gamma Knife radiosurgery

    • Eline Verhaak
    • Wietske C. M. Schimmel
    • Karin Gehring

    Clinical Study Open access 26 July 2019 Pages: 377 - 384

16. Cysts associated with intramedullary ependymomas of the spinal cord: clinical, MRI and oncological features

    • Corentin Dauleac
    • Rostom Messerer
    • Cédric Y. Barrey

    Clinical Study 23 July 2019 Pages: 385 - 391

    

17. Stereotactic radiosurgery in elderly patients with brain metastases: comparison with non-elderly patients using database of a multi-institutional prospective observational study (JLGK0901-Elderly)

    • Yoshinori Higuchi
    • Masaaki Yamamoto
    • Hidefumi Aoyama

    Clinical Study 23 July 2019 Pages: 393 - 402

    

18. Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

    • Thomas J. Kaley
    • Katherine S. Panageas
    • Andrew B. Lassman

    Clinical Study 19 July 2019 Pages: 403 - 407

19. Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective study

    • Eike Steidl
    • Mathias Müller
    • Elke Hattingen

    Clinical Study 18 July 2019 Pages: 409 - 417

    

20. Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study

    • M. C. Morisse
    • N. Etienne-Selloum
    • B. Chauffert

    Clinical Study 19 July 2019 Pages: 419 - 426

    

21. Correction to: Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes

    • Abdurrahman I. Islim
    • Midhun Mohan
    • Michael D. Jenkinson

    Correction Open access 31 July 2019 Pages: 427 - 429

22. Retraction Note to: Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis

    • Yoshihiro Sato
    • Yoshiaki Honda
    • Eiichiro Honda

    Retraction Note 29 July 2019 Pages: 431 - 431